December 9 2020: Our study entitled Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 by Popa, Genger et al. is published in Science Translational Medicine and on the cover. Link to our study:
November 18 2020: Please refer to our new SARS-CoV-2 project website http://www.sarscov2-austria.org.
June 18 2020: Two and a half months later and still not back to the old normal. If you want to find out more about our SARS-CoV-2 related activities, please visit the project website http://www.cemm.at/sars-cov-2. Thank you for your interest!
April 3 2020: Viruses in every headline, institutes nearly closed and public life pretty much in lock-down. Unusual but also busy and challenging times since we mounted a highly collaborative project to sequence the first SARS-CoV-2 genomes from Austria. Today we released the first 21 patient-derived SARS-CoV-2 genomes to the public databases GISAID and nextstrain.org. See also the phylogenetic tree below. We pledged to do another 980 virus genomes within the next few weeks (press release). This project is a community effort involving multiple people from CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Medical University of Vienna and several additional collaboration partners from across and beyond Austria. Additional partners are very much encouraged to contact us. Updates about our results will be presented here.
We are grateful that this project received funding by the Vienna Science and Technology Fund (WWTF) through its COVID-19 Rapid Response Call.
Nov 26: Our study about cytokine-driven reprogramming liver metabolism is online in Immunity!
Link to paper (Open Access)
May 20: Our study about infection-associated cachexia is published in Nature Immunology!
January 14: Our study about the molecular insights into the transmissible cancer of Tasmanian devils is finally out and published in Cancer Cell!